ADVISORY-Alert incorrectly tagged to Curis Inc withdrawnAn alert on Danish drugmaker Curasight A/S CURAS.TE announcing successful dosing of a patient in its brain cancer drug trial was inadvertently tagged to U.S.-based Curis Inc CRIS.O, an unrelated entity, and has been withdrawn.
There will be no substitute
STORY_NUMBER:nTUA1WR1VX
STORY_DATE:18th December, 2025
STORY_TIME:06:46PM GMT
((Bangalore.newsroom@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments